Sitagliptin/Simvastatin

Background The purpose of this study was to review the current literature and information on the combination product Juvisync™ (sitagliptin + simvastatin), which was approved by the US Food and Drug Administration in October 2011. Methods PubMed (2001–2014) was searched for primary and review articl...

Full description

Saved in:
Bibliographic Details
Main Author: Ramadan, Wijdan H. (author)
Other Authors: Kabbara, Wissam K. (author)
Format: article
Published: 2016
Online Access:http://hdl.handle.net/10725/4485
http://dx.doi.org/ 10.2147/VHRM.S79198
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334171/
Tags: Add Tag
No Tags, Be the first to tag this record!